Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.

× No keyword cloud information.

9 in total

1. DETERMINATION OF GOLD IN SERUM AND URINE BY NEUTRON ACTIVATION ANALYSIS.

Authors: S SOLVSTEN
Journal: Scand J Clin Lab Invest Date: 1964 Impact factor: 1.713

2. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors:
Journal: Ann Rheum Dis Date: 1959-03 Impact factor: 19.103

3. The place of gold compounds in the treatment of rheumatoid arthritis.

Authors: R H FREYBERG
Journal: J Chronic Dis Date: 1957-06

4. Increasing the effectiveness of gold therapy in rheumatoid arthritis.

Authors: R T SMITH; W P PEAK; K M KRON; I F HERMANN; R A DELTORO; M GOLDMAN
Journal: J Am Med Assoc Date: 1958-07-05

5. The Curative Effect of Certain Gold Compounds on Experimental Proliferative, Chronic Arthritis in Mice.

Authors: A B Sabin; J Warren
Journal: J Bacteriol Date: 1940-12 Impact factor: 3.490

6. METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors: R H Freyberg; W D Block; S Levey
Journal: J Clin Invest Date: 1941-07 Impact factor: 14.808

7. Gold Treatment in Rheumatoid Arthritis.

Authors: T N Fraser
Journal: Ann Rheum Dis Date: 1945-06 Impact factor: 19.103

8. Studies with radioactive gold.

Authors: J S LAWRENCE
Journal: Ann Rheum Dis Date: 1961-12 Impact factor: 19.103

9. Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors: A Lorber; R L Cohen; C C Chang; H E Anderson
Journal: Arthritis Rheum Date: 1968-04

9 in total

16 in total

1. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.

Authors: C J Danpure; D A Fyfe; J M Gumpel
Journal: Ann Rheum Dis Date: 1979-08 Impact factor: 19.103

Review 2. Clinical pharmacokinetics of oral and injectable gold compounds.

Authors: K L Blocka; H E Paulus; D E Furst
Journal: Clin Pharmacokinet Date: 1986 Mar-Apr Impact factor: 6.447

Review 3. Monitoring gold plasma levels in rheumatoid arthritis.

Authors: A Lorber
Journal: Clin Pharmacokinet Date: 1977 Mar-Apr Impact factor: 6.447

4. Tissue gold levels after chrysotherapy.

Authors: R Grahame; R Billings; M Laurence; V Marks; P J Wood
Journal: Ann Rheum Dis Date: 1974-11 Impact factor: 19.103

5. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.

Authors: J D Jessop; R G Johns
Journal: Ann Rheum Dis Date: 1973-05 Impact factor: 19.103

6. Serum gold. II. Levels in rheumatoid arthritis.

Authors: H M Rubinstein; A A Dietz
Journal: Ann Rheum Dis Date: 1973-03 Impact factor: 19.103

7. Use of yttrium 90 in persistent synovitis of the knee. I. Retention in the knee and spread in the body after injection.

Authors: J M Gumpel; E D Williams; H I Glass
Journal: Ann Rheum Dis Date: 1973-05 Impact factor: 19.103

Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.